// App-Quantinova.ai

: A Post Hoc Analysis of SUSTAIN 9

Researchers

Presenter

  • BERNARD ZINMAN

Principal Investigators

  • VAISHALI BHOSEKAR

  • ROBERT S. BUSCH

  • INGRID HOLST

  • BERNHARD LUDVIK

  • JAMES THRASHER

  • VINCENT C. WOO

Medical Centers

  • N/A

Locations

  • Canada

  • India

  • United States

  • Denmark

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic ketoacidosis

  • Type 2 diabetes mellitus

  • Diabetes

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • Luseogliflozin

  • BI-10773

  • Canagliflozin

  • Dapagliflozin

  • Ipragliflozin

  • tofogliflozin

  • Metformin controlled release

  • sulfonylureas

  • Semaglutide

  • Metformin Hydrochloride

  • Intranasal glucagon

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved